DEC 17, 2019 2:00 PM SGT

Towards HCV Elimination, a Case Study of Taiwan

Speaker
  • Distinguished Professor - Kaohsiung Medical University, Kaohsiung, Taiwan - Adjunct Professor, College of Biological Science and Technology, National Chiao Tung University, Hsin-Chu, Taiwan
    Biography
      Ming-Lung Yu, MD, PhD, is the Vice President of Kaohsiung Medical University, Taiwan. Professor Yu, a board-certified internist and gastroenterologist, is currently teaching at the Kaohsiung Medical University and Kaohsiung Medical University Hospital. Currently, he is also a Adjunct Professor at College of Biological Science and Technology, National Chiao-Tung University, Hsin-Chu, Taiwan, and at Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.

      Professor Yu's research interests in epidemiology and natural history of viral hepatitis have led him to publish more than 280 journal and review articles. Professor Yu has won numerous awards over his career in recognition of his research. In addition to his academic and clinical achievements, Professor Yu also holds various editorial roles with several scientific journals some of which include PLoS ONE, World Journal of Gastroenterology, and Korean Journal of Hepatology. He also frequently serves as a reviewer for major international journals in medicine, gastroenterology and hepatology, such as The Lancet, Gastroeneterology, Hepatology, Gut, Journal of Hepatology, Clinical Infectious Disease, Canadian Medical Association Journal, Thorax, Ontotarget, Pharmacology & Therapeutics, Scientific Reports and Journal of Infectious Diseases

    Abstract

    DATE: December 17, 2019
    TIME: 2:00pm SGT

     

    From WHO 2017 Hepatitis report, an estimated 290 million (89%) of the 325 million people living with viral hepatitis B and C are unaware that they are infected. As such, "Find the Missing Millions" Campaign was launched on Hepatitis Day 2019 to raise awareness and take action to influence real change. 

    How are countries adapting to reach the goal of Hepatitis elimination by 2030? Let us hear from what Taiwan have to offer from their Micro-Elimination strategies in stepping up their efforts to overcome the barriers to Viral Hepatitis Testing. 

     

    Learning Objectives:

    • To be able to identify the different treatment options for HCV with genotypic and pan-genotypic drug regimens
    • To recognize the challenge and barriers to HCV Elimination from awareness to linkage of care.
    • To summarize how increasing the accessibility to HCV diagnostics is critical in achieving Global HCV Elimination

     

    Webinars will be available for unlimited on-demand viewing after live event.

     

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    APR 21, 2021 10:00 AM PDT
    C.E. CREDITS
    APR 21, 2021 10:00 AM PDT
    Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
    APR 19, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 19, 2021 8:00 AM PDT
    Date: Apri 19, 2021 Time: 8:00am PDT, 5:00pm CEST Since the inception of modern biological research, BioSafety has evolved into a critical consideration in Good Laboratory Practices (GLP). Wi...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    APR 20, 2021 11:00 AM PDT
    C.E. CREDITS
    APR 20, 2021 11:00 AM PDT
    Date: April 20, 2021 Time: 11:00am (PST), 2:00pm (EST) Identification and confirmation of microbial isolates is crucial in the analysis workflow, providing decision-makers the information...
    MAY 18, 2021 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 18, 2021 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 18, 2021 Time: 8:00am (PST) The global pandemic has caused an increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provide qu...
    DEC 17, 2019 2:00 PM SGT

    Towards HCV Elimination, a Case Study of Taiwan


    Specialty

    Laboratory Testing

    Immunology

    Infectious Disease

    Clinical Diagnostics

    Molecular Biology

    Molecular Diagnostics

    Microbiology

    Clinical Chemistry

    Cancer Diagnostics

    Cancer Research

    Pcr/rt-Pcr/real-Time Pcr

    Genetics

    Diagnostics

    Biochemistry

    Cell Biology

    Geography

    North America71%

    Asia13%

    Europe9%

    South America3%

    Oceania2%

    Africa1%

    Registration Source

    Website Visitors59%

    Email Promotions29%

    WAVE Newsletter Promotion8%

    Trending Newsletter Promotion2%

    Other2%

    Job Title

    Medical Laboratory Technician31%

    Clinical Laboratory Scientist15%

    Lab Management11%

    Facility/Department Manager10%

    Executive7%

    Medical Doctor/Specialist5%

    Educator/Faculty5%

    Research Scientist4%

    Student3%

    Marketing/Sales2%

    Chemist2%

    Biologist2%

    QC/QA2%

    Scientist2%

    Organization

    Hospital24%

    Clinical Laboratory19%

    Academic Institution10%

    Diagnostic Company6%

    Medical Center5%

    Government5%

    Medical Device Company3%

    Biotech Company3%

    Government/public3%

    Research Institute2%

    General Laboratory2%

    Pharmaceutical Company2%

    Life Science Company2%

    Non-Profit Organization2%

    Other2%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more